Financial Statements — DRTS
Balance Sheet
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 |
|---|
| Cash & Equivalents | 11.70 | 2.76 | 0.86 |
| Short-term Investments | 68.00 | 68.27 | 92.67 |
| Total Current Assets | 85.78 | 75.25 | 96.06 |
| Property, Plant & Equipment | 17.29 | 12.35 | 7.55 |
| Total Non-current Assets* | 25.18 | 20.80 | 15.15 |
| Total Assets | 110.95 | 96.05 | 111.21 |
| Accounts Payable | -- | -- | 1.79 |
| Total Current Liabilities | 8.16 | 6.46 | 5.42 |
| Long-term Debt | -- | 20.26 | -- |
| Total Non-current Liabilities | 16.18 | 15.58 | 13.23 |
| Total Liabilities | 24.33 | 22.03 | 18.64 |
| Retained Earnings | (166.31) | (131.11) | (103.48) |
| Total Stockholder Equity | 86.62 | 74.02 | 92.56 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2025 | Q2
2024 | Q2
2023 |
|---|
| Research & Development | 14.18 | 13.31 | 12.26 |
| Selling, General & Admin | 3.86 | 3.03 | 3.63 |
| Operating Income | (18.96) | (17.48) | (16.81) |
| Pretax Income | (18.64) | (15.35) | (16.83) |
| Tax Provision | 0.16 | 0.00 | 0.05 |
| Net Income | (18.80) | (15.35) | (16.88) |
| Basic EPS | (0.25) | (0.22) | (0.24) |
| Diluted EPS | (0.25) | (0.22) | (0.24) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 |
|---|
| Operating Cash Flow | (14.61) | (12.80) | (9.92) |
| Capital Expenditures | 3.21 | 0.12 | 0.59 |
| Free Cash Flow* | (17.82) | (12.92) | (10.51) |
| Investing Cash Flow | (24.19) | 2.87 | 4.97 |
| Financing Cash Flow | 36.76 | 0.03 | 0.00 |
* Derived from reported values
